ACTIVE SUBSTANCE / INN

TRIAMTERENE

Brand name(s): TRIAMTERENE, MAXZIDE, MAXZIDE-25, DYRENIUM, TRIAMTERENE AND HYDROCHLOROTHIAZIDE, DYAZIDE
FDA LISTED
PRESCRIPTION
DISCONTINUED
ANDA211581
ANDA071980
ACTIVE SUBSTANCE
Triamterene
REGULATORS
FDA
SPONSORS / MAH
WATSON LABS, AGNITIO, AUROBINDO PHARMA USA
TOTAL APPLICATIONS
7
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
TRIAMTERENE AND HYDROCHLOROTHIAZIDEANDA071980QUANTUM PHARMICSDiscontinued
TRIAMTERENEANDA211581AGNITIOPrescription
DYRENIUMNDA013174ADVANZ PHARMAPrescription
TRIAMTERENE AND HYDROCHLOROTHIAZIDEANDA071851WATSON LABSPrescription
DYAZIDENDA016042GLAXOSMITHKLINE LLCDiscontinued
MAXZIDE-25NDA019129AUROBINDO PHARMA USAPrescription
MAXZIDENDA019129AUROBINDO PHARMA USAPrescription

FULL INTELLIGENCE ON TRIAMTERENE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →